기사 리스트형 웹진형 타일형 Similar survival seen with neoadjuvant chemo, chemoradiotherapy for esophageal cancer NEW YORK (Reuters Health) By Reuters Staff - Survival does not differ for patients with resectable esophageal cancer who are treated with neoadjuvant chemoradiotherapy and chemotherapy, respectively, according to new findings.Current National Comprehensive Cancer Network (NCCN) guidelines recommend 2016-10-19 22:14 처음처음1끝끝
